Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Jo Potter Formation: 3 - 5 - 2 Manager: Luke Turner Formation: 3 - 4 - 2 ...
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Manager: Karen Hills Formation: 4 - 4 - 2 Manager: Simon Parker Formation: 4 - 4 - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback